In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
Publication|Articles|August 14, 2025
- Pharmaceutical Commerce - August 2025
- Volume 20
- Issue 4
Pharmaceutical Commerce: August 2025 Interactive Digital Edition
View the Pharmaceutical Commerce August 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
about 1 year ago
A Pharma Wholesaler Scorecardabout 1 year ago
The Tariff Saga Continuesabout 1 year ago
DSCSA Compliance Has Arrived. Now What?about 1 year ago
Pharma Wholesalers: Looking for Growthabout 1 year ago
Caveat Emptor in the Gray Marketabout 1 year ago
Insurance Barriers Delaying Patient CareAdvertisement
Related to this article
Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.
PhRMA's lawsuit argues CMS overstepped its demonstration authority by tying Medicare Part B rebates to international prices.
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation.
At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.
Swisslog's Mark Beers discusses how software helps pharma supply chains adapt to shifting portfolios, strengthen inventory verification and build trust.
At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains.
McKesson's Chris Van Norman previews his LogiPharma USA keynote on demand signal sharing, AI, and precision distribution for targeted therapies.
Advertisement
Advertisement